Fig. 1From: Recommendations from the European Working Group for Value Assessment and Funding Processes in Rare Diseases (ORPH-VAL)Process through which the Principles were developed. MoCA-OMP: mechanism of coordinated access to orphan medicinal products; MCDA: multi-criteria decision analysis; P&R: Pricing and reimbursement; TC: teleconferenceBack to article page